Services: Lytham Partners, LLC (“Lytham”) provides a range of investor relations services to its clients. The particular services provided vary by client and may change from time to time.
No Investment Advice: Lytham is not a registered broker-dealer, registered investment adviser or financial adviser, nor does it hold itself out to be. All materials presented on this website and/or publications or presentations released by Lytham to the public through this website, email, or any other means of transmission are not to be regarded as investment advice, do not constitute an endorsement of the company, and are only for informative purposes. Before making a purchase or sale of any securities mentioned on this website or in Lytham’s publications or presentations, Lytham strongly encourages and recommends consultation with a registered securities representative. This website and/or publications or presentations released by Lytham to the public through this website, email, or any other means of transmission do not constitute an offer to purchase or sell securities, and is not to be construed as a representation of an offer or a solicitation of any offer by Lytham or its client companies to purchase or sell any security. Lytham or any of its affiliates, members, employees, clients, officers, directors, and/or their respective families may from time to time purchase or sell, as agents or principals, or otherwise hold positions in, securities of its client companies, and are free to buy or sell those positions at will. Any such positions may be increased or decreased from time to time in the future without notice. Any information or opinions expressed in this website and/or publications or presentations released by Lytham are subject to change without notice.
Compensation Information: Lytham is compensated by its clients for providing certain investor relations services, such as consulting, preparation of collateral materials, arranging non-deal roadshows, and other investor relations related services. Lytham’s clients and the compensation provided are as follows: Acasti Pharam compensates Lytham at a rate of $9,500 per month. AppTech compensates Lytham at a rate of $9,500 per month. Arianne Phosphate Inc. compensates Lytham at a rate of $6,500 per month. Aurora Spine compensates Lytham at a rate of $7,500 per month. Aytu BioPharma compensates Lytham at a rate of $12,500 per month. Cadrenal Therapeutics compensates Lytham at a rate of $9,500 per month. Lytham currently owns 82,000 shares of Cadrenal Therapeutics. Charles & Colvard compensates Lytham at a rate of $9,500 per month. Cosmos Holdings compensates Lytham at a rate of $9,500 per month. Delcath compensates Lytham at a rate of $7,000 per month. Else Nutrition compensates Lytham at a rate of $3,000 per month. GSE Systems, Inc. compensates Lytham at a rate of $7,500 per month. HUB Security compensates Lytham at a rate of $10,500 per month. ImmuCell Corporation compensates Lytham at a rate of $10,000 per quarter. Lytham currently has 10,000 options to purchase shares of ImmuCell. InfuSystem Holdings, Inc. compensates Lytham at a rate of $7,500 per month. INVO Bioscience, Inc. compensates Lytham at a rate of $8,500 per month. Lytham currently owns 55,626 restricted shares of INVO Bioscience. L.B. Foster compensates Lytham at a rate of $7,500 per month. LiqTech International, Inc. compensates Lytham at a rate of $7,500 per month. LiveWorld compensates Lytham at a rate of $6,500 per month. Mogo Inc. compensates Lytham at a rate of $3,750 per month. Opsens Inc. compensates Lytham at a rate of $7,000 per month. Precision Optics Corporation compensates Lytham at a rate of $5,000 per month. Lytham currently owns 8,333 restricted shares of Precision Optics Corporation. Perimeter Medical Imaging AI Inc. compensates Lytham at a rate of $6,000 per month. Reliq Health Technologies Inc. compensates Lytham at a rate of $6,000 per month. Reviva compensates Lytham at a rate of $7,500 per month. Scientific Industries, Inc. compensates Lytham at a rate of $7,500 per month. SenesTech, Inc. compensates Lytham at a rate of $7,500 per month. Lytham currently owns 237 shares of SenesTech. Shuttle Pharmaceuticals compensates Lytham at a rate of $9,500 per month. S&W Seed Company compensates Lytham at a rate of $6,000 per month. Lytham currently owns 10,000 shares of S&W Seed Company. Trinity Biotech compensates Lytham at a rate of $6,000 per month. Zoomd compensates Lytham at a rate of $2,000 per month. Companies not mentioned, but participating at a Lytham Partners Virtual Investor Conference, typically paid $3,500 to participate in the event. Click here for a list of Lytham’s former clients over the last three years and the compensation they paid.
Information Sources and Forward-Looking Statements: The information contained in this website and/or publications or presentations about Lytham’s clients was obtained from materials available to the general public, including the clients’ filings with the SEC, documents included on the client’s websites, information provided by the client or from other publicly available sources deemed reliable by Lytham. Lytham does not represent or guarantee the accuracy or completeness of this information. This information is subject to change without notice and Lytham assumes no responsibility to update the information, except as required by law. The information contained in this website and/or publications or presentations about Lytham’s clients may contain “forward‐looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (“Reform Act”), as well as Regulation FD. These statements may involve risks and uncertainties that could cause actual results to differ materially from the forward‐looking statements. Factors which could cause or contribute to such differences are detailed in the company’s public filings with the United States Securities and Exchange Commission, if available. Forward‐looking statements speak only as of the date the statement was made. Neither the company nor Lytham undertakes, and specifically disclaims, any obligation to update any forward‐looking statements. The company claims the protection of the safe‐harbor for forward‐looking statements contained in the Reform Act. Any performance data quoted represents past performance of the company. There is no guarantee of comparable future results; current performance may be higher or lower.
Roger Weiss is a highly regarded member of the Wall Street institutional sales community. In a career spanning more than 30 years, he has held senior sales management positions at leading sell-side firms including B. Riley/National Securities, Canaccord Genuity, A.G. Edwards, and First Manhattan Co. He also has extensive commercial banking experience serving at J.P. Morgan Chase (Manufacturers Hanover Trust) and PNC Financial. Roger holds a Bachelor of Arts degree from Vanderbilt University and an MBA, with concentrations in Accounting and Finance from the Columbia Business School.
Ben Shamsian has been an equities analyst on the buyside and sell side for over thirteen years. Prior to joining Lytham, Ben was a senior analyst at FNY Capital, Sterne Agee and Iridian Asset Management, where he covered consumer, industrial, technology, energy, and business services sectors. Ben has expertise in uncovering the value of equities through financial modeling, management interviews, and industry research. Throughout his career, many management and investor relations teams have seeked Ben’s advice as to how to better communicate with their investors. Ben began his career in accounting with PWC and Merrill Lynch, and obtained his CPA license. Ben holds a BS in Accounting from Yeshiva University and an MBA in Finance from New York University’s Stern School of Business.
Adam Lowensteiner has been closely involved with micro and small-cap companies his entire career. Prior to joining Lytham, Adam was a Senior Account Executive at Wolfe Axelrod Weinberger Associates, an investor relations agency based in New York City. For thirteen years Adam worked intimately with the CEOs and CFOs of emerging growth companies seeking to expand the investor audience base. Prior to working at Wolfe Axelrod Weinberger, Adam worked as a sellside analyst with CJS Securities in White Plains, New York, as a generalist, but focused on small cap stocks. Prior to CJS, Adam worked several years with Individual Investor Group in New York City as a Senior Research Analyst, mostly researching micro and small cap ideas for the company’s various publications and investment vehicles. Adam graduated from the Sy Syms School of Business at Yeshiva University with a Bachelors of Science in Finance.
Rolf has worked in the investor relations field for more than 15 years. He is responsible for gathering research materials and assisting in the organization of materials for road shows and 1×1 meetings. His focus is on researching and data analysis at the institutional level. Prior to that, he worked with international commerce. He holds degrees from the University of Iowa.
Brittany is a creative and resourceful marketing professional with 10 years of design, social media management and special event experience. She specializes in creating processes for heightened customer journeys through strategic and imaginative print and digital campaigns as well as creating and maintaining strong brands within the organizations she works for. Brittany has worked in a variety of industries in both the public and private sectors including Hospitality & Tourism, Education and Renewable Energy.
Kristen oversees creative programs and design concepts and plays an essential role in the marketing, communications and creative needs of our organization and client companies. For more than 15 years she has been applying her creative talents to developing collateral materials, annual report concepts and design, website design and development, social media and email marketing campaigns, digital and traditional print advertising. Additionally, Kristen manages all aspects of client press release distribution and quarterly earnings event logistics. She has a B.A. degree in English from Marist College and studied Computer Graphic Design at Phoenix College.
Robert Breza’s background includes 30 years of finance and technology experience including 19 years on Wall Street with Tier 1 firms such as the Royal Bank of Canada (RBC) for 10 years and technology focused firms such as Thomas Weisel Partners during the Internet boom and bust in San Francisco and Stern Agee. Rob has worked with large companies such as Microsoft and Oracle and many smaller companies taking 16 companies public (IPO’s). Rob has an MBA from the University of Minnesota – Carlson School of Management and a B.S. in Accounting from St. Cloud State University – Herberger School of Business. Rob resides in Scottsdale, AZ.
In a career spanning more than 25 years Joe Diaz has extensive experience in advising and counseling corporate management teams on operational and valuation issues. He has been instrumental in crafting and executing strategic programs that have yielded significant enhancement of shareholder value –including AdvancePCS (now Caremark Rx, Inc.), Allied Waste, Inc. (NYSE: AW), Bio-Rad Laboratories (AMEX: BIO), CNS, Inc. (NASDAQ: CNXS) and Abaxis, Inc. (NASDAQ: ABAX), among others. With a background in portfolio management Joe maintains a strong belief that investors in the small cap arena are actually “investing” in management teams than can consistently grow businesses, rather than innovative products and services. His primary focus is on establishing and maintaining management credibility. An alumnus of Coe College, Joe, along with his wife Pat, is an avid equestrian, sports fan and free market capitalist.
Joe has a strong track record for the management, design and implementation of strategic plans to enhance shareholder value for leading-edge companies. In a career that spans more than 25 years, he has successfully delivered strategic investor relations services to clients and provides unique insight on quarterly earnings materials, investor conferences, non-deal roadshows, IPOs, and analyst-investor days. Leveraging his extensive knowledge of industry fundamentals and his direct experience with investor decision-making, he has been responsible for overseeing significant capital appreciation for client companies under his direct management. He was previously affiliated with a leading regional investment banking and securities firm and was responsible for initiating and operating the first United Mexican States Federal Treasury Certificate (CETES) desk in Arizona. Joe holds a B.A. degree from Arizona State University.
Robert is a 20-year investor relations industry veteran, with an expertise in understanding the dynamics and requirements of a successful relationship between public companies and the capital markets. During his career, Robert has overseen the development and implementation of every critical component of a successful investor relations campaign, including the execution of thousands of non-deal roadshow meetings, conference 1×1’s and management conference calls as well as other critical investor outreach components such as creation of the firm’s institutional corporate profiles and virtual conference initiatives. His ability to successfully guide his clients corporate positioning resides in his ability to articulate a company’s value proposition through benchmarks and metrics that easily resonate with the national investment community, streamlining these components throughout press releases, conference call scripts, investor presentations, websites, and annual reports. In addition to traditional investor relations activities, Robert has consulted the management and board of directors on a number of capital markets activities, including having guided numerous companies through the uplisting process from the OTC to Nasdaq and/or NYSE, cross listing of shares from a foreign exchange to the U.S., proxy contest situations, capital raise evaluation, merger/acquisition valuation impact, crisis communications, perception analysis, and board of director/management recruitment. Robert spearheaded the campaign and created the relationships that resulted in a client being named “Stock of the Decade” as the #1 performing stock for 2000-2010. An alumnus of Arizona State University, he holds a B.A. degree in Finance.
Thank you for expressing interest in attending our conference! Complete the form below and a member of our team will reach out shortly.
We’re excited to meet you! Complete the form below and a member of our team will be in touch.
Complete the form below and a member of our team will reach out shortly.